Caribou Biosciences stock plunges 40% on halt of CAR-T programs
Investing.com· Investing.com· Oct 6, 2026 · 8:47 PM
This is a summary. Read the complete story at Investing.com below.
Read full article at Investing.comRelated Stories
stocksabout 5 hours ago
Yum Brands earnings beat estimates, but cyclospora outbreak weighs on Taco Bell
Taco Bell's same-store sales declined as a Cyclospora outbreak tied to lettuce served at its restaurants weighed on traffic.
CNBC Stocks
stocksabout 5 hours ago
Versant earnings beat expectations as digital platforms drive growth
Versant posted third-quarter earnings that beat Wall Street expectations and reaffirmed its full-year guidance.
CNBC Stocks
stocksabout 5 hours ago
Pfizer hikes full-year outlook, taps company veteran as new CFO
Pfizer announced that Cecile Guegan, who has held various leadership roles at the company over the last 20 years, stepped in as CFO this month.
CNBC Stocks